Overseas-registered Products Available For Cyclophosphamide And Ifosfamide Injection Shortages

Recall Summary Cyclophosphamide and ifosfamide injections registered overseas are being made available in Australia due to shortages of the regularly supplied versions of these cancer treatment drugs. This is a Class III recall affecting drug supplies across Australia. Patients currently using or prescribed these medications may be impacted by changes to their drug supply source.

Reason

Information about the cyclophosphamide and ifosfamide injection shortages.

Classification

Class III

Category

drug recall

Country

Australia

Agency

Therapeutic Goods Administration

Recall date

2026-04-22

Status

Ongoing

Distribution

Australia-wide

Official recall notice from Therapeutic Goods Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/5befaebb-384d-4bbc-aaa2-68e710584071